WebMD Health Corp.’s (WBMD) Buy Rating Reaffirmed at Leerink Swann
A number of other analysts have also commented on the company. Zacks Investment Research raised WebMD Health Corp. from a sell rating to a hold rating in a research note on Tuesday, September 20th. Mizuho reissued a buy rating and set a $63.00 price target (down from $68.00) on shares of WebMD Health Corp. in a research note on Monday, September 19th. KeyCorp cut their price target on WebMD Health Corp. from $74.00 to $72.00 and set an overweight rating on the stock in a research note on Tuesday, August 16th. Goldman Sachs Group Inc. reissued a neutral rating and set a $62.00 price target on shares of WebMD Health Corp. in a research note on Thursday, August 11th. Finally, Citigroup Inc. lifted their price target on WebMD Health Corp. from $62.00 to $64.00 and gave the company a neutral rating in a research note on Tuesday, August 9th. Five equities research analysts have rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the stock. The company has a consensus rating of Buy and an average target price of $64.79.
Shares of WebMD Health Corp. (NASDAQ:WBMD) traded up 1.22% during trading on Wednesday, hitting $51.26. The company had a trading volume of 226,324 shares. WebMD Health Corp. has a 12-month low of $39.67 and a 12-month high of $67.55. The stock has a 50-day moving average of $51.65 and a 200 day moving average of $59.02. The stock has a market capitalization of $1.92 billion, a price-to-earnings ratio of 31.56 and a beta of 0.70.
WebMD Health Corp. (NASDAQ:WBMD) last announced its quarterly earnings results on Monday, August 8th. The company reported $0.39 EPS for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.01. WebMD Health Corp. had a return on equity of 40.02% and a net margin of 11.05%. The firm had revenue of $167.60 million for the quarter, compared to analyst estimates of $165.46 million. During the same period last year, the firm posted $0.32 earnings per share. The business’s revenue for the quarter was up 13.0% on a year-over-year basis. On average, analysts predict that WebMD Health Corp. will post $1.82 EPS for the current fiscal year.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Meeder Asset Management Inc. acquired a new position in WebMD Health Corp. during the first quarter valued at $115,000. LS Investment Advisors LLC acquired a new position in WebMD Health Corp. during the second quarter valued at $134,000. BlackRock Inc. boosted its position in WebMD Health Corp. by 131.1% in the first quarter. BlackRock Inc. now owns 2,491 shares of the company’s stock valued at $156,000 after buying an additional 1,413 shares in the last quarter. Parametrica Management Ltd acquired a new position in WebMD Health Corp. during the first quarter valued at $203,000. Finally, Tower Research Capital LLC TRC boosted its position in WebMD Health Corp. by 11,003.1% in the second quarter. Tower Research Capital LLC TRC now owns 3,553 shares of the company’s stock valued at $207,000 after buying an additional 3,521 shares in the last quarter. 84.19% of the stock is currently owned by institutional investors and hedge funds.
WebMD Health Corp. Company Profile
WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications. The WebMD Health Network includes: www.WebMD.com, its primary public portal for consumers and related mobile-optimized sites and mobile apps; www.Medscape.com, its primary public portal for physicians and other healthcare professionals and related mobile services; and other sites through which, the Company provides its branded health and wellness content, tools and services.
Receive News & Stock Ratings for WebMD Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WebMD Health Corp. and related stocks with our FREE daily email newsletter.